Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China
· Delayed Price · Currency is CNY 25.87
-0.06 (-0.23%)
Apr 29, 2026, 3:04 PM CST
SHE:300357 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 425.83 | 380.94 | 317.82 | 310.18 | 348.77 | 337.99 | Upgrade
|
| Depreciation & Amortization | 55.58 | 55.58 | 50.81 | 38.46 | 26.08 | 25.07 | Upgrade
|
| Other Amortization | 1.88 | 1.88 | 2.28 | 0.95 | 1.94 | 1.95 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.63 | -0.63 | -0.57 | - | 0.27 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.11 | 5.11 | 1.42 | 0.58 | 43.23 | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.15 | -6.15 | -6.47 | -1.24 | -2.69 | -6.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.61 | 0.61 | 0.86 | -1 | 1.24 | 1.55 | Upgrade
|
| Other Operating Activities | -87.56 | -11.83 | -12.32 | -13.26 | -11.32 | -11.29 | Upgrade
|
| Change in Accounts Receivable | 9.03 | 9.03 | -99.79 | 66 | -30.95 | -34.58 | Upgrade
|
| Change in Inventory | 2.98 | 2.98 | 1.3 | -9.39 | 4.1 | -5.42 | Upgrade
|
| Change in Accounts Payable | -14.21 | -14.21 | 7.69 | -9.16 | -20.92 | 52.47 | Upgrade
|
| Operating Cash Flow | 392.36 | 423.2 | 262.44 | 382.08 | 360.28 | 360.58 | Upgrade
|
| Operating Cash Flow Growth | 28.83% | 61.25% | -31.31% | 6.05% | -0.08% | 40.73% | Upgrade
|
| Capital Expenditures | -126.17 | -152.29 | -129.32 | -227.47 | -200.66 | -124.25 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | 0.02 | 0 | 0.22 | - | Upgrade
|
| Investment in Securities | -123.8 | -123.08 | -478.84 | 5.93 | 24.6 | -109.05 | Upgrade
|
| Other Investing Activities | 9.6 | 3.5 | 12.54 | 29.66 | 57.64 | 20.99 | Upgrade
|
| Investing Cash Flow | -240.36 | -271.88 | -595.6 | -191.87 | -118.19 | -212.31 | Upgrade
|
| Short-Term Debt Issued | - | 20 | 2.76 | 24.99 | - | - | Upgrade
|
| Total Debt Issued | 10 | 20 | 2.76 | 24.99 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -27.63 | -44.12 | -20 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -6.18 | -7.79 | -8.56 | -5.79 | -5.81 | Upgrade
|
| Total Debt Repaid | -16.23 | -33.81 | -51.91 | -28.56 | -5.79 | -5.81 | Upgrade
|
| Net Debt Issued (Repaid) | -6.23 | -13.81 | -49.15 | -3.57 | -5.79 | -5.81 | Upgrade
|
| Common Dividends Paid | -115.26 | -115.3 | -97.45 | -105.62 | -105.24 | -83.77 | Upgrade
|
| Other Financing Activities | -0.08 | - | 0.01 | 85.78 | - | - | Upgrade
|
| Financing Cash Flow | -121.58 | -129.11 | -146.58 | -23.41 | -111.03 | -89.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0.01 | 0.01 | 0.01 | 0.02 | -0.01 | Upgrade
|
| Net Cash Flow | 30.41 | 22.2 | -479.73 | 166.8 | 131.08 | 58.67 | Upgrade
|
| Free Cash Flow | 266.19 | 270.9 | 133.12 | 154.61 | 159.62 | 236.33 | Upgrade
|
| Free Cash Flow Growth | 46.62% | 103.50% | -13.89% | -3.14% | -32.46% | 27.02% | Upgrade
|
| Free Cash Flow Margin | 24.49% | 25.50% | 14.39% | 18.23% | 17.82% | 29.26% | Upgrade
|
| Free Cash Flow Per Share | 0.51 | 0.52 | 0.25 | 0.29 | 0.30 | 0.45 | Upgrade
|
| Cash Income Tax Paid | 129.07 | 123.18 | 98.34 | 80.89 | 114.73 | 39.38 | Upgrade
|
| Levered Free Cash Flow | 64.31 | 135.92 | 95.1 | 100.31 | 41.7 | 125.17 | Upgrade
|
| Unlevered Free Cash Flow | 64.82 | 136.42 | 95.77 | 101.13 | 41.98 | 125.4 | Upgrade
|
| Change in Working Capital | -2.32 | -2.32 | -91.39 | 47.41 | -47.24 | 11.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.